|
Triflusal Versus Aspirin in Secondary Stroke Prevention: Results of TACIP Study
Jordi Matias-Guiu
|
|
Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing serious vascular events in high vascular risk patients.
Graeme J Hankey
|
|
Embolic Signal Variability in Patients with Asymptomatic Carotid Artery Stenosis.
Anne L Abbott
|
|
Effect of Ca Antagonist on Development and Extension of Asymptomatic as well as Symptomatic CVD (first report)- Design and first year's result of the PICA Study -
Yukito Shinohara
|
|
Major adverse cardiac events in the ESPS-2 trial
Hans-Christoph Diener
|
|
The Appropriateness of Antithrombotic Therapy After Stroke or TIA in Patients with Non-Valvular Atrial Fibrillation
Christine A Fawcett
|
|
Clinical trials vs. clinical reality
Martin Grond
|
|
ESPRIT: mild anticoagulation, acetylsalicylic acid plus dipyridamole or acetylsalicylic acid alone after cerebral ischaemia of arterial origin
Jaap Kappelle
|
|
The adverse effects of different doses of aspirin: a systematic overview of randomised trials and observational studies
Cathie LM Sudlow
|